Neutralizing HMGB1 activity by administration of anti-HMGB1 antibodies or ethyl pyruvate attenuates colon injury, reduces weight loss and improves colon scores in animal models of colitis [13], [14], [17], [18]. This evidence concerns the gene HMGB1 and colitis.